Dexcel Pharma

Dexcel Pharma

Is it you?
Investor info
Type
Venture Capital
Stage focus
  • Other
Industry focus
Description
Dexcel Pharma is Israel’s largest private pharmaceutical company. Founded in 1968, they develop, manufacture and market value-added branded and generic pharmaceuticals. With a diverse product portfolio that spans more than 55 branded and generic products in over 140 dosage forms, our products are sold in the US, the UK and Germany, via subsidiaries and through a trusted network of partners in more than 30 countries worldwide.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
X Feed
See other investors focused on
Pharmaceuticals
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.